Literature DB >> 32885550

Risk factors for cerebral palsy in neonates due to placental abruption.

Kiyotake Ichizuka1,2, Satoshi Toyokawa1,3, Tsuyomu Ikenoue1,4, Shoji Satoh1,5, Junichi Hasegawa1,6, Tomoaki Ikeda1,7, Nanako Tamiya1,8, Akihito Nakai1,9, Keiya Fujimori1,10, Tsugio Maeda1,11, Naohiro Kanayama1,12, Hideaki Masuzaki1,13, Mitsutoshi Iwashita1,14, Hideaki Suzuki1, Satoru Takeda1,15.   

Abstract

AIM: This study aimed to identify risk factors for the onset of cerebral palsy (CP) in neonates due to placental abruption and investigate their characteristics.
METHODS: A retrospective case-control study was conducted using a nationwide registry from Japan. The study population included pregnant women (n = 122) who delivered an infant with CP between 2009 and 2015, where placental abruption was identified as the single cause of CP. The control group consisted of pregnant women with placental abruption, who delivered an infant without CP and were managed from 2013 to 2014. They were randomly identified from the prenatal database of the Japan Society of Obstetrics and Gynecology (JSOG-DB; n = 1214). Risk factors were investigated using multivariate analysis.
RESULTS: Alcohol consumption (3.38, 2.01-5.68) (odds ratio, 95% confidence interval), smoking during pregnancy (3.50, 1.32-9.25), number of deliveries (1.28, 1.05-1.56), polyhydramnios (5.60, 1.37-22.6), oral administration of ritodrine hydrochloride (2.09, 1.22-3.57) and hypertensive disorders in pregnancy (2.25, 1.27-4.07) were significant risk factors. In contrast, intravenous administration of oxytocin (odds ratio, 95% confidence interval: 0.22, 0.09-0.58) and magnesium sulfate (0.122, 0.02-0.89) attenuated risk.
CONCLUSION: Alcohol consumption, smoking during pregnancy, number of deliveries, polyhydramnios, oral administration of ritodrine hydrochloride and hypertensive disorders in pregnancy were identified as risk factors for CP following placental abruption. Regarding alcohol consumption and smoking during pregnancy, the results suggest the importance of educational activities targeting pregnant women to increase their awareness of placental abruption.
© 2020 The Authors. Journal of Obstetrics and Gynaecology Research published by John Wiley & Sons Australia, Ltd on behalf of Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  alcohol consumption; cerebral palsy; placental abruption; risk factors; smoking

Mesh:

Year:  2020        PMID: 32885550      PMCID: PMC7818445          DOI: 10.1111/jog.14447

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  18 in total

1.  Placental abruption and perinatal mortality in the United States.

Authors:  C V Ananth; A J Wilcox
Journal:  Am J Epidemiol       Date:  2001-02-15       Impact factor: 4.897

2.  A checklist to identify the origin of cerebral palsy.

Authors:  Mariarosaria Di Tommaso; Andrea Tranquilli
Journal:  J Matern Fetal Neonatal Med       Date:  2004-05

3.  Heavy maternal alcohol consumption and cerebral palsy in the offspring.

Authors:  Colleen M O'Leary; Linda Watson; Heather D'Antoine; Fiona Stanley; Carol Bower
Journal:  Dev Med Child Neurol       Date:  2012-01-23       Impact factor: 5.449

4.  Placental abruption in the United States, 1979 through 2001: temporal trends and potential determinants.

Authors:  Cande V Ananth; Yinka Oyelese; Lami Yeo; Archana Pradhan; Anthony M Vintzileos
Journal:  Am J Obstet Gynecol       Date:  2005-01       Impact factor: 8.661

Review 5.  A template for defining a causal relationship between acute intrapartum events and cerebral palsy: international consensus statement. International Cerebral Palsy Task Force.

Authors:  A MacLennan
Journal:  Aust N Z J Obstet Gynaecol       Date:  2000-02       Impact factor: 2.100

6.  Adverse obstetric and perinatal outcomes of singleton pregnancies may be related to maternal factors associated with infertility rather than the type of assisted reproductive technology procedure used.

Authors:  Masako Hayashi; Akihito Nakai; Shoji Satoh; Yoshio Matsuda
Journal:  Fertil Steril       Date:  2012-07-02       Impact factor: 7.329

7.  No. 376-Magnesium Sulphate for Fetal Neuroprotection.

Authors:  Laura A Magee; Dane A De Silva; Diane Sawchuck; Anne Synnes; Peter von Dadelszen
Journal:  J Obstet Gynaecol Can       Date:  2019-04

Review 8.  A systematic review of risk factors for cerebral palsy in children born at term in developed countries.

Authors:  Sarah McIntyre; David Taitz; John Keogh; Shona Goldsmith; Nadia Badawi; Eve Blair
Journal:  Dev Med Child Neurol       Date:  2012-11-26       Impact factor: 5.449

Review 9.  A Controversial Medicolegal Issue: Timing the Onset of Perinatal Hypoxic-Ischemic Brain Injury.

Authors:  Vittorio Fineschi; Rocco Valerio Viola; Raffaele La Russa; Alessandro Santurro; Paola Frati
Journal:  Mediators Inflamm       Date:  2017-08-13       Impact factor: 4.711

10.  Relevant Obstetric Factors for Cerebral Palsy: From the Nationwide Obstetric Compensation System in Japan.

Authors:  Junichi Hasegawa; Satoshi Toyokawa; Tsuyomu Ikenoue; Yuri Asano; Shoji Satoh; Tomoaki Ikeda; Kiyotake Ichizuka; Nanako Tamiya; Akihito Nakai; Keiya Fujimori; Tsugio Maeda; Hideaki Masuzaki; Hideaki Suzuki; Shigeru Ueda
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

View more
  3 in total

1.  Risk factors of cerebral palsy in children: a systematic review and meta-analysis.

Authors:  Dandan Chen; Meiyuan Huang; Yangyan Yin; Dongmei Gui; Yuniao Gu; Taiping Zhuang; Caihua Chen; Kaiming Huo
Journal:  Transl Pediatr       Date:  2022-04

2.  Epidemiology, Risk Factors, and Perinatal Outcomes of Placental Abruption-Detailed Annual Data and Clinical Perspectives from Polish Tertiary Center.

Authors:  Monika Bączkowska; Katarzyna Kosińska-Kaczyńska; Magdalena Zgliczyńska; Robert Brawura-Biskupski-Samaha; Beata Rebizant; Michał Ciebiera
Journal:  Int J Environ Res Public Health       Date:  2022-04-23       Impact factor: 4.614

3.  Habitual Smoking and Perinatal Outcomes in Japan.

Authors:  Shunji Suzuki
Journal:  Cureus       Date:  2022-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.